Onderneming Cellectar Biosciences Inc Nasdaq
Aandelen
US15117F2039
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Caruso
CEO | Chief Executive Officer | 65 | 15-06-15 |
Chad Kolean
DFI | Director of Finance/CFO | 59 | 28-05-14 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-23 |
Jarrod Longcor
COO | Chief Operating Officer | 51 | 15-07-16 |
Shane Lea
PRN | Corporate Officer/Principal | - | 21-11-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 07-04-17 |
Douglas Swirsky
CHM | Chairman | 54 | 07-04-17 |
John Neis
BRD | Director/Board Member | 68 | 01-02-08 |
James Caruso
CEO | Chief Executive Officer | 65 | 15-06-15 |
Stefan Loren
BRD | Director/Board Member | 60 | 15-06-15 |
Director/Board Member | 55 | 24-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 238 | 0 | 0 | 90,91 % |
Aandeel B | 0 | 111 | 0 | 0 | |
Aandeel C | 1 | 35 848 924 | 32 591 316 ( 90,91 %) | 0 |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. | |
-0,45% | 162 mld. |
- Beurs
- Aandelen
- Koers CLRB
- Koers
- Onderneming Cellectar Biosciences Inc